JDQ443 for KRAS G12C NSCLC Brain Metastases
Condition(s):Non Small Cell Lung Cancer Metastatic; Brain Metastases, Adult; KRAS G12CLast Updated:March 13, 2024Not yet recruiting
Hide Studies Not Open or Pending
Condition(s):Non Small Cell Lung Cancer Metastatic; Brain Metastases, Adult; KRAS G12CLast Updated:March 13, 2024Not yet recruiting
Condition(s):KRAS G12CLast Updated:August 16, 2023Recruiting
Condition(s):KRAS G12C Mutant Advanced Solid TumorsLast Updated:February 1, 2024Recruiting
Condition(s):Solid TumorLast Updated:January 18, 2024Recruiting
Condition(s):Locally Advanced or Metastatic KRAS G12C-mutated NSCLC With a PD-L1 Expression <1% or a PD-L1 Expression ≥ 1% and an STK11 Co-mutationLast Updated:February 28, 2024Recruiting
Condition(s):Advanced Cancer; Metastatic Cancer; Malignant Neoplasm of LungLast Updated:March 15, 2024Recruiting
Condition(s):Solid Tumor, Adult; NSCLC; Advanced Cancer; Metastatic Cancer; Malignant Neoplastic DiseaseLast Updated:February 5, 2024Recruiting
Condition(s):Lung Cancer; Non Small Cell Lung Cancer; Colorectal Cancer; Cancer of Pancreas; Colon Cancer; Solid Tumor; CancerLast Updated:September 13, 2023Recruiting
Condition(s):Advanced Solid Tumor; NSCLC; CRCLast Updated:September 7, 2023Recruiting
Condition(s):Neoplasms; Advanced Solid Tumors; Non-small Cell Lung Cancer; Colorectal CancerLast Updated:November 6, 2020Completed
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.